Elevation Point Wealth Partners LLC increased its position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 30.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,739 shares of the semiconductor company’s stock after acquiring an additional […]

Elevation Point Wealth Partners LLC bought a new stake in shares of Innovator Defined Wealth Shield ETF (BATS:BALT – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 157,443 shares of the company’s stock, valued at approximately $5,269,000. […]

Elevation Point Wealth Partners LLC increased its holdings in Astrazeneca Plc (NYSE:AZN – Free Report) by 212.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,217 shares of the company’s stock after purchasing an additional 30,746 shares during the quarter. Elevation […]